EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biomimetic Tumour Model Systems for Pancreatic Ductal Adenocarcinoma in Relation to Photodynamic Therapy

Olivia M Smith iD, Nicole Lintern iD, Jiahao Tian iD, Bárbara M Mesquita, Sabrina Oliveira iD, Veronika Vymetalkova iD, Jai Prakash iD, Andrew M Smith, David G Jayne, Michal Heger, Yazan S Khaled iD, Photodynamic Therapy Study Group

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136388 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Olivia M Smith und 11 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Medical Research, St. James's University Teaching Hospital, Leeds LS9 7TF, UK. Hauptthemen laut MEDLINE: Photochemotherapy, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Biomimetics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 398 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Medical Sciences, European Union – Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and is associated with poor prognosis. Despite years of research and improvements in chemotherapy regimens, the 5-year survival rate of PDAC remains dismal. Therapies for PDAC often face resistance owing in large part to an extensive desmoplastic stromal matrix. Modelling PDAC ex vivo to investigate novel therapeutics is challenging due to the complex tumour microenvironment and its heterogeneity in native tumours. Development of novel therapies is needed to improve PDAC survival rates, for which disease models that recapitulate the tumour biology are expected to bear utility. This review focuses on the existing preclinical models for human PDAC and discusses advancements in tissue remodelling to guide translational PDAC research. Further emphasis is placed on photodynamic therapy (PDT) due to the ability of this treatment modality to not only directly kill cancer cells by minimally invasive means, but also to perturb the tumour microenvironment and elicit a post-therapeutic anti-tumour immune response. Accordingly, more complex preclinical models that feature multiple biologically relevant PDAC components are needed to develop translatable PDT regimens in a preclinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyCarcinoma, Pancreatic DuctalPancreatic NeoplasmsBiomimeticsHumansTumor MicroenvironmentAnimalsPhotosensitizing Agents

Stichwörter der Autor:innen

2-D and 3-D cell culturecancer modelscell deathcell viability assayschemotherapyin vitro analysispancreaspatient-derived xenograftsphotodynamic therapypreclinical testingspheroids and organoids

Substanzen

Photosensitizing Agents

Autor:innen und Institutionen

  • Leeds Institute of Medical Research, St. James's University Teaching Hospital, Leeds LS9 7TF, UK.
  • Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics, Department of Pharmaceutics, College of Medicine, Jiaxing University, Jiaxing 314001, China.
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands.
  • Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 00 Prague, Czech Republic.
  • Engineered Therapeutics Group, Department of Advanced Organ Bioengineering and Therapeutics, Technical Medical Centre, University of Twente, 7522 NB Enschede, The Netherlands.
  • School of Medicine, The University of Leeds, LS2 9JT Leeds, UK.

ORCID-Profile: Olivia M Smith, Nicole Lintern, Jiahao Tian, Sabrina Oliveira, Veronika Vymetalkova, Jai Prakash, Yazan S Khaled

Förderung

  • Academy of Medical Sciences
  • European Union – Next Generation EU

Zitieren

APA

Smith, O. M., Lintern, N., Tian, J., Mesquita, B. M., Oliveira, S., Vymetalkova, V., Prakash, J., Smith, A. M., Jayne, D. G., Heger, M., Khaled, Y. S., & Photodynamic Therapy Study Group (2025). Biomimetic Tumour Model Systems for Pancreatic Ductal Adenocarcinoma in Relation to Photodynamic Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136388

Vancouver

Smith OM, Lintern N, Tian J, Mesquita BM, Oliveira S, Vymetalkova V, et al. Biomimetic Tumour Model Systems for Pancreatic Ductal Adenocarcinoma in Relation to Photodynamic Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136388

BibTeX
@article{Smith2025,
  author = {Smith, Olivia M and Lintern, Nicole and Tian, Jiahao and Mesquita, Bárbara M and Oliveira, Sabrina and Vymetalkova, Veronika and Prakash, Jai and Smith, Andrew M and Jayne, David G and Heger, Michal and Khaled, Yazan S and Photodynamic Therapy Study Group, Photodynamic Therapy Study Group},
  title = {Biomimetic Tumour Model Systems for Pancreatic Ductal Adenocarcinoma in Relation to Photodynamic Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136388}
}
Kostenlos starten →